A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.

Slides:



Advertisements
Similar presentations
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Advertisements

Global Measles and Rubella Strategic Plan
New Technologies for Tuberculosis Control: Programme Perspective Draft Definitions Retooling Task Force Meeting Geneva, Switzerland January 2008.
Towards a model M&E system for AIDS programs Kampala April
Lessons Learned in Social Protection in health Group 8.
Donald T. Simeon Caribbean Health Research Council
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
“Concepts in evaluation of vaccination programs in low income countries" Jagrati Jani Section for International Health Department of Community Medicine.
FROM CRISIS RESPONSE TO INCLUSIVE GROWTH By Chada Koketso.
HIGHLIGHTS OF MDGs & MKUZA II IN ZANZIBAR
Role of the laboratory in disease surveillance
Health Aspect of Disaster Risk Assessment Dr AA Abubakar Department of Community Medicine Ahmadu Bello University Zaria Nigeria.
Immunization and the Convention on the Rights of the Child What would it take to achieve universal coverage? Daniel Tarantola M.D. Professor of Health.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
OIC-SHPA & Vaccines Need Assessment in OIC Member Countries
Goal 4: Reduce child mortality Existing Target 5 Reduce by two thirds between 1990 and 2015 the Under Five Mortality Rate Proposed Target 5 Reduce by.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Process of Development of Five Year Strategic Plan for Child Health Development Dr Myint Myint Than Deputy Director (WCHD) Department of Health.
Civil Society in Decision Making for Immunization Policies: the example of National Immunization Technical Advisory Groups (NITAGs) Center for Vaccine.
The National Vaccine Plan Process - Update October 22, 2007 Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services.
Midterm Review of Health and Nutrition Sector 22 – 23 June 2009, Baghdad.
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
Future Directions for the Public Health Division Future Directions for the Public Health Division Presentation to the Annual General Meeting Association.
(CAREC) PAHO/WHO Serving 21 Member Countries in the English and Dutch Speaking Caribbean Preparations for the Next Pandemic (or Epidemic or Outbreak) Leslie.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
Expanded Program of Immunization Dr. Faten M. Rabie.
Multi-Year Plans Strengthening immunization systems and introduction of hepatitis B vaccine in Central Europe and the Newly Independent States St. Petersburg,
Sri Lankan Perspective Dr Nihal Abeysinghe M.B.,B.S., MSc, M.D. (Community Medicine) Chief Epidemiologist Ministry of Health, Nutrition & Welfare Place.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
DRAFT V1 National Vaccine Supply Chain Innovations: Country Commitment to Ownership, Sustainability & Impact GAVI Partners’ Forum WHO – UNICEF – GAVI -
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
HEALTH SYSTEMS Keerti Bhusan Pradhan
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Ministry of Healthcare & Nutrition Broader Approaches to Health Strategic Frame Work for Health Development.
MILLENIUM DEVELOPMENT GOALS Board review Notes Dr. Theresita R. Lariosa.
Removing the pump handle Formulating recommendations.
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
Dr, Janbaz Afridi Deputy Director EPI Khyber Pakhtunkhwa
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
New Vaccines in Developing Countries: Evidence, Practice, Policy, and Challenges Global Vaccines 202X: Access, Equity, Ethics Philadelphia, USA 2 May 2011.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
Expanded program of Immunization (EPI) Introduction The Expanded Program on Immunization (EPI) was established in 1974 depending on the success of the.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
GHANA HEALTH SERVICE, EASTERN REGION MID-YEAR REVIEW 2014 WAY FORWARD BY RDHS.
Public Health Options for Implementing Vaccine Recommendations: A Framework for State Decision Making Donald Williamson, M.D. National Vaccine Advisory.
Adult Immunization: Goals, Challenges, and a role for the National Vaccine Advisory Committee October 22, 2007 Raymond A. Strikas, MD National Vaccine.
The National Vaccine Plan Update: Recent Activities and Next Steps Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human.
THE NATIONAL VACCINE PROGRAM OFFICE NATIONAL ADULT IMMUNIZATION PLAN OVERVIEW.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
IMCI Implementation in Ghana Initial assessment 1998 Adaptation phase ( ) Early implementation ( ): 4 focus districts Scale-up: 5-year.
2004 Pan American Health Organization Immunizations-PAHO Strengthening National Immunization Technical Advisory Groups in the Americas Jon K. Andrus Barbara.
ORGANIZATION CAPACITY ASSESSMENT (2013) Produced in April 2013.
Scottish Improvement Science Collaborating Centre Strengthening the evidence base for improvement science: lessons learned Dr Nicola Gray, Senior Lecturer,
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
Complex Emergency Response: Are We Prepared? Lebanon Experience Seventh Global Measles Partners Meeting 27 – 28 th February 2007, Washington D.C. Dr. Mirza,
Presentation to the Health Portfolio Committee Presentation to Health Portfolio Committee Free State Department of Health 15 APRIL 2003.
National Health Strategy
Measles & Rubella Initiative Partners meeting September 7-8, 2017
<COUNTRY NAME> EPI REVIEW
Stakeholder Consultation
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
The STOP TB Strategy – 2009 VISION: A TB-free world
National Health Policy and Strategic Shifts
National one Health Strategy( )
Presentation transcript:

A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of Health

Immunization Programme Sri Lanka : Vaccines used at present  BCG for Tuberculosis  Oral polio for Poliomyelitis  DPT / DT for Diphtheria, Pertusis [Whooping Cough] & Tetanus  Measles  Rubella  Tetanus  Hepatitis B  Japanese Encephalitis

Present status of the Immunization Programme, Sri Lanka  Dramatic reduction in illness, disability & death from Poliomyelitis (0) since 1994 Diptheria (0) in 2005 Tetanus (25) / Neonatal Tetanus (0) Whooping Cough (32) Measles (24) Childhood tuberculosis Japanese Encephalitis Rubella  Very high vaccine coverage > 95%

Decision Making Process  Evidence based decision making  Epidemiology Unit recognizes the needs  Makes addition to the surveillance system  Carries out burden & cost studies  Proposes to the Advisory Committee on Communicable Diseases  Reviewed & approved by the Advisory Committee on Communicable Diseases [ACCD]  Discussion with a wider group of stakeholders; [ “ Immunization Summit-held on 5 th January 2007”]  Negotiate for funding & convince the Finance Ministry  Acquire logistics, other facilities & prepare the field staff  Develop a communication strategy  Develop plans for Continuous follow up, Monitoring & Evaluation

Strength of the Sri Lankan EPI : Number of Years Taken to Reach Over 90% Coverage Following Introduction of a New Vaccine

Present Challenges  Sustaining high coverage  Achieving eradication & elimination targets  Ensuring vaccines of assured quality  Introducing new vaccines  Strengthening the capacity for surveillance of Vaccine-preventable diseases & Adverse Events following immunizations  Ensuring financial sustainability for the immunization programme  Strengthening Primary Health care system

Cost Considerations in the National EPI  Introduction of a new vaccine is always considered within the framework of the National EPI, not separately  Total cost Vaccine Injection supplies Other routine recurrent cost  Cold chain equipment  Transportation

Policies that would help us to achieve the desired status  Equity and equality  Ownership, partnership and responsibility Government Other stakeholders International organizations  Accountability publicly accountable for the policies, goals, strategies and actions  Assured quality, safe products and services Internationally recognized standards of quality, safety, and services are delivered according to best practices.

Policies that would help us to achieve the desired status  Adaptability to local needs and circumstances commitment of all responsible stakeholders to appropriately adapt to the local needs and circumstances.  Sustainability through technical and financial capacity building All stakeholders including the government should work collectively, to ensure financial and technical self reliance with continuing, incremental infrastructure building.  Policies and strategies based on evidence and best practices The choice of policies, strategies and practices should be based on evidence from surveillance, monitoring and evaluation, operational research, diseases burden and impact assessments, and economic analyses

Key Strategies  Implementing the comprehensive Multi Year Plan & annual plans  Reaching children in “difficult to reach areas”  Ensuring quality vaccine supply & accessories  Improving quality services by enhancing the service facilities, vaccine storage capacity & surveillance of Adverse Events Following Immunization  Creating a Community demand  Introducing new vaccines to combat ‘emerging’ new VPD with financial sustainability plans  Regular reviewing of the programme “What works & What not”

Key Strategies  Ensuring financial sustainability  Improving National regulatory authority activities by regular discussions  Promoting operational research : Disease Burden studies  Improving management of human resources  Strengthening laboratory capacity  Strengthening capacity for data management  Planning for immunization in complex emergencies  Develop & implement a comprehensive communication strategy  Include immunization in epidemic preparedness plans  Define & delegate responsibilities to stakeholders

Thank you Epidemiology Unit Ministry of Health